Methodological considerations in TriNetX research: Reflections on SGLT2i use post-TAVR in heart failure patients

Authors

• Abdalhakim Shubietah, Advocate Health - MidwestFollow
• Ahmed Emara, Al-Azhar University, Cairo, Egypt.
• Elsayed Balbaa, Alexandria University, Alexandria, Egypt.

Recommended Citation

Shubietah A, Emara A, Balbaa E. Methodological Considerations in TriNetX Research: Reflections on SGLT2i Use Post-TAVR in Heart Failure Patients. JACC Adv. Published online May 12, 2026. doi:10.1016/j.jacadv.2026.102797

Affiliations

Advocate Illinois Masonic Medical Center

Type

Letter

PubMed ID

42119375